DEA proposes 2027 production quotas for Schedule I and II controlled substances and list I chemicals
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2027
The US Drug Enforcement Administration has proposed 2027 aggregate production quotas for Schedule I and II controlled substances and an assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine and phenylpropanolamine. Written comments are due by December 10, 2026, under Docket No. DEA-1730P, after which the Administrator will publish a final order.
Key facts
- Kind of item
- Guidance and consultations
- Regulator
- DEA (United States)
- Jurisdiction
- United States
- Source
- Federal Register: DEA and FDA documents (US) (federalregister.gov)
- Published
- Original
- Read it at federalregister.gov
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Federal Register: DEA and FDA documents (US) · federalregister.gov
Connected to
- Kind of item
- Guidance and consultations
- Regulator
- DEA (United States)
- Jurisdiction
- United States